JD Health International Inc.
6618
Ранг среди акций
#1398
JD Health International Inc., functioning as an investment holding entity, runs... JD Health International Inc., functioning as an investment holding entity, runs an expansive digital healthcare platform across the People's Republic of China. The company supplies a diverse range of pharmaceutical and wellness products, such as over-the-counter and prescription medications, medical devices, and health supplements. These goods are distributed through both direct sales and an extensive online retail pharmacy network. Beyond product offerings, its comprehensive service suite includes virtual medical consultations, patient referrals to hospitals and doctors, health screening programs, genetic testing, and beauty care services. Additionally, it develops intelligent healthcare and wellness management solutions, alongside providing technical support and advertising services. The platform also facilitates access to various medical provisions, including general health examinations, cosmetic medical procedures, vaccination bookings, dental treatments, and nucleic acid testing. Incorporated in 2018 and headquartered in Beijing, People's Republic of China, JD Health International Inc. is a subsidiary of JD Jiankang Limited.
Цена акции
$4.88
Рыночная капитализация
$15.57B
Изменение (1 день)
-1.59%
Изменение (1 год)
-38.67%
Страна
CN
Торговля JD Health International Inc. (6618)
Категория
Healthcare
Выручка компании JD Health International Inc. (6618)
Выручка на Jun 2026 TTM: $11.37B
Согласно последним финансовым отчетам JD Health International Inc., текущая выручка компании (TTM) составляет $11.37B. В 2023 году компания получила выручку $7.56B больше, чем выручке в 2022 году, которая составила $6.78B. Выручка — это общий доход, который компания получает от продажи товаров или услуг. В отличие от прибыли, расходы не вычитаются.
История выручки JD Health International Inc. с 2017 по 2026
Выручка на конец каждого года
| Год | Выручка | Изменить |
|---|---|---|
| 2026 (TTM) | $11.37B | 42.72% |
| 2024 | $7.97B | 5.37% |
| 2023 | $7.56B | 11.61% |
| 2022 | $6.78B | 40.35% |
| 2021 | $4.83B | 62.70% |
| 2020 | $2.97B | 90.55% |
| 2019 | $1.56B | 31.11% |
| 2018 | $1.19B | 39.14% |
| 2017 | $853.51M | 0.00% |
Выручка аналогичных компаний или конкурентов
| Компания | Выручка | Разница в выручке | Страна |
|---|---|---|---|
| $78.01B | 586.00% |
US
|
|
| - | - |
DE
|
|
| $21.81B | 91.80% |
US
|
|
| $3.89B | -65.75% |
SA
|
|
| $11.08B | -2.53% |
BR
|
